In this chronic HDM-driven asthma model, genetic ablation of TSLPR attenuated airway hyperresponsiveness and reduced Th1 and Th2 cytokine levels and allergen-specific IgE, without altering airway remodeling or total inflammatory cell infiltration. The gene discussed is IGHE; the disease is airway hyperresponsiveness.